Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel von Herrero Rivera, Daniel, Vacas, Carmen Garrigós, Kovandzic, Laura Marcos, Vázquez, Javier Puente, Alonso, Lucía A, González, Begoña Mellado, Aragón, Verónica Calderero, Grande, Enrique, Caro, Raquel Luque, Virizuela Echaburu, Juan A, Rodríguez Moreno, Juan F, Etxebarria, Ainara A, Rodríguez-Antona, Cristina, Durán, Ignacio

Volltext

TMIC-76. GLIOBLASTOMA VESSEL CO-OPTION OCCURS AS A RESISTANCE MECHANISM TO CHEMORADIATION VIA INDUCTION OF A NOVEL CELL STATE von Pettiwala, Aafrin M, Pichol-Thievend, Cathy, Anezo, Oceane, Bourmeau, Guillaume, Montagne, Remi, Lyne, Anne-Marie, Guichet, Pierre-Olivier Guichet, Deshors, Pauline, Ballestin, Alberto, Blanchard, Benjamin, Ravi, Vidhya M, Joseph, Kevin, Heiland, Dieter Henrik, Julien, Boris, Leboucher, Sophie, Besse, Laetitia, Legoix, Patricia, Furumaya, Charita, Marcos, Laura Kovandzic, Masliantsev, Konstantin, Daubon, Thomas, Schnell, Oliver, Beck, Jürgen, Servant, Nicolas, Karayan-Tapon, Lucie, Cavalli, Florence, Seano, Giorgio

Volltext

Single nucleotide polymorphisms (SNPs) as predictors of efficacy of cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC) von Rivera, Daniel Herrero, Duran, Ignacio, Marcos Kovandzic, Laura, Puente, Javier, Mellado, Begona, Grande, Enrique, Virizuela, Juan Antonio, Rodriguez-Moreno, Juan Francisco, Azueta, Ainara, Alonso Buznego, Lucia Andrea, Luque, Raquel, Garrigos, Carmen

Volltext